4//SEC Filing
Maxwell John T. 4
Accession 0001214659-20-007366
CIK 0001398733other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 8:55 AM ET
Size
4.8 KB
Accession
0001214659-20-007366
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Sale
Common Stock
2020-08-18$8.00/sh−3,000$24,000→ 150,614 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 16, 2020.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001739025
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 8:55 AM ET
- Size
- 4.8 KB